Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
The review focuses on these drugs metabolic impacts, spanning diabetic hyperglycemia, fatty liver disease, peripheral metabolism, and insulin resistance enhancement
For example, individuals with type 2 diabetes may use it for blood sugar control
It substantially improves overall health, transforming physical and emotional well-being
The cost of semaglutide, particularly when used for weight loss (under the brand name Wegovy), tends to be on the higher end compared to other weight loss medications